Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease

Abstract Background Osteoprotegerin (OPG) and osteopontin (OPN) are vascular calcification inhibitors with a known role in the atherosclerotic and inflammatory process. We investigated their relationship with adverse outcomes (restenosis/adverse cardiovascular events) after endovascular revascularis...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Nikolaos P. E. Kadoglou, Dimitrios Kapetanios, Emmanouil Korakas, Georgia Valsami, Nikolaos Tentolouris, Nikolaos Papanas, Vaia Lambadiari, Christos Karkos
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2022-09-01
Saila:	Cardiovascular Diabetology
Gaiak:	Osteoprotegerin Osteopontin Peripheral artery disease MACE Inflammation
Sarrera elektronikoa:	https://doi.org/10.1186/s12933-022-01605-6
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!